11 hours ago:

Description:

Professor Angus Dalgleish, (Fellow of the Royal College of Physicians, Fellow of the Royal College of Pathologists, Fellow of Medical Science.)

Professor Dalgleish is a highly experienced doctor, physician, medical teacher, medical author and researcher with over 500 primary research publications.

He was also a pioneering researcher into HIV/AIDS.

Here we discuss the recently observed changes in cancer presentations and deaths. Some of the discussion considers this research paper noting excess cancer deaths in Japan.

Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan

www.cureus.com/articles/196275-increased-age-adjus…

Gibo M, Kojima S, Fujisawa A, et al. (April 08, 2024) Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan. Cureus 16(4): e57860. DOI 10.7759/cureus.57860

Conclusions

Statistically significant increases in age-adjusted mortality rates of all cancer and some specific types of cancer, namely, ovarian cancer, leukemia, prostate, lip/oral/pharyngeal, pancreatic, and breast cancers, were observed in 2022 after two-thirds of the Japanese population had received the third or later dose of SARS-CoV-2 mRNA-LNP vaccine.

These particularly marked increases in mortality rates of these ER?-sensitive cancers may be attributable to several mechanisms of the mRNA-LNP vaccination,

rather than COVID-19 infection itself or reduced cancer care due to the lockdown.

Researchers have reported that the SARS-CoV-2 mRNA-LNP vaccine may pose the risk of development and progression of cancer.

Several case reports have described cancer developing or worsening after vaccination and discussed possible causal links between cancer and mRNA-LNP vaccination.

Description:

Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan

www.cureus.com/articles/196275-increased-age-adjus…

Gibo M, Kojima S, Fujisawa A, et al. (April 08, 2024) Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan. Cureus 16(4): e57860. DOI 10.7759/cureus.57860

Conclusions

Statistically significant increases in age-adjusted mortality rates of all cancer and some specific types of cancer, namely, ovarian cancer, leukemia, prostate, lip/oral/pharyngeal, pancreatic, and breast cancers, were observed in 2022 after two-thirds of the Japanese population had received the third or later dose of SARS-CoV-2 mRNA-LNP vaccine.

These particularly marked increases in mortality rates of these ER?-sensitive cancers may be attributable to several mechanisms of the mRNA-LNP vaccination,

rather than COVID-19 infection itself or reduced cancer care due to the lockdown.

Researchers have reported that the SARS-CoV-2 mRNA-LNP vaccine may pose the risk of development and progression of cancer.

Several case reports have described cancer developing or worsening after vaccination and discussed possible causal links between cancer and mRNA-LNP vaccination.

Details of the paper

No significant excess mortality was observed during the first year of the pandemic (2020).

However, some excess cancer mortalities were observed in 2021 after mass vaccination with the first and second vaccine doses,

and significant excess mortalities were observed for all cancers and some specific types of cancer after mass vaccination with the third dose in 2022.

During the COVID-19 pandemic

Excess deaths including cancer have become a concern in Japan

Study aimed to evaluate how age-adjusted mortality rates (AMRs) for different types of cancer in Japan changed during the COVID-19 pandemic (2020-2022).

Official statistics from Japan,

used to compare observed annual and monthly AMRs,

with predicted rates based on pre- pandemic (2010-2019) figures

In 2020

(first year of the pandemic)

Significant deficit mortality for all causes, and no excess mortality for all cancers.

In 2021

Significant excess mortality of 2.1% for all causes,

and 1.1% for all cancers.

In 2022

Excesses mortality, 9.6%

2.1% for all cancers

Number of excess deaths 115,799

Number of excess cancer deaths, 7,162

Lung, colorectal, stomach, pancreatic, and liver cancer

Accounted for 61% of deaths from all cancers.

AMRs for the four cancers with the most deaths showed a decreasing trend until the first year of the pandemic in 2020,

but the rate of decrease slowed in 2021 and 2022.

Since February 2021, the mRNA-lipid nanoparticle (mRNA-LNP) vaccine has been available for emergency use,

and is recommended for all aged six months and older

As of March 2023

80% of the Japanese population had received first and second doses,

68% had received third dose,

45% had received fourth dose

Excess deaths from causes other than COVID-19 have been reported in various countries, including deaths from cancer,

and Japan is no exception

Japan, good data

Large population of 123 million

Availability of official statistics

80% accuracy rate of death certificates according to autopsy studies

Vaccination rates by age group, the websites of the Prime Minister’s Office and the Ministry of Health, Labor and Welfare

Discussion

All cancer deaths: A statistically significant excess emerged in 2021 and increased further in 2022.

In addition, significant excess monthly mortality was observed after August 2021,

whereas mass vaccination of the general population began around April 2021.

There were excess trends in cancer deaths across most age groups.

The significant increases in mortalities for six specific cancer types were unlikely to be explained by a shortage of healthcare services.

The description:

Pfizer, bringing discredit to pharmaceutical industry
www.pmcpa.org.uk/media/cwvkqvyz/3741-case-report-2…

www.telegraph.co.uk/news/2024/04/06/pfizer-breache…

Senior executives used social media to promote an “unlicensed” Covid vaccine.

Pfizer found to have breached the regulatory code five times,

Prescription Medicines Code of Practice Authority (PMCPA)

Pharmaceutical watchdog,

relates to a complaint about a message posted on twitter

November 2020 by senior Pfizer employees.

COMPLAINT
the complainant alleged that it turned out that such misbehaviour was even more widespread than they had thought, extended right to the top of their UK operation and was apparently continuing to this very day.

PANEL RULING
The Panel noted Pfizer’s submission that on further investigation into this complaint four other Pfizer UK colleagues, including another senior colleague in the UK organisation, had re-tweeted the same post.
The Panel queried whether a social media platform, such as Twitter was the appropriate forum to share such information.
The Panel noted the tweet contained limited information regarding the efficacy of the vaccine candidate with no safety information provided.
On the balance of probabilities, it was likely that the Pfizer UK employee’s connections would include UK members of the public as well as UK health professionals.
The Panel noted that the tweet clearly referred to the outcome of the Pfizer and BioNTech’s vaccine being developed to protect against COVID-19.
The Panel noted that Clause 3.1 prohibited the promotion of a medicine prior to the grant of its marketing authorisation.
They must not mislead either directly or by implication, by distortion, exaggeration or undue emphasis. Material must be sufficiently complete to enable the recipient to form their own opinion of the therapeutic value of the medicine.
It must not be stated that a product has no adverse reactions, toxic hazards or risks of addiction or dependency. The Panel noted the tweet made no reference to adverse events and was therefore concerned that important safety information relating to the vaccine candidate was not provided and ruled a breach of Clause 7.9 of the 2019 Code as acknowledged by Pfizer.
The Panel noted Pfizer stated that the senior employee whose re-tweet was the subject of this complaint had completed the social media training module in October 2019.
Activity which was clearly outside of company policy had not been taken down or deleted.

‘Unlicensed medicine proactively disseminated’

“unlicensed medicine being proactively disseminated on Twitter to health professions and members of the public in the UK”.

Pfizer UK spokesman

“fully recognises and accepts the issues highlighted by this PMCPA ruling”,

“deeply sorry”.

Pfizer

‘Accidental and unintentional’

Sixth time Pfizer has been reprimanded by the regulator over its promotion of the Covid-19 vaccine.

Ben Kingsley, UsForThem

“It’s astonishing how many times Pfizer’s senior executives have been found guilty of serious regulatory offences – in this case including the most serious offence of all under the UK Code of Practice.

“Yet the consequences for Pfizer and the individuals concerned continue to be derisory. This hopeless system of regulation for a multi-billion dollar life and death industry has become a sham, in dire need of reform.”

The description of the video (Google suppresses the topic):

The spike protein exhibits pathogenic characteristics

www1.racgp.org.au/ajgp/2024/april/long-covid-suffe…

Multiple studies have shown an increased risk of myocarditis after vaccination with mRNA encoding SARS-CoV-2 spike protein.

mRNA vaccines can result in spike protein expression in

Muscle tissue

Lymphatic system

Cardiomyocytes

Other cells after entry into the circulation.

There is concern that COVID-19 vaccination per se might contribute to long COVID,

giving rise to the colloquial term ‘Long Vax(x)’

pubmed.ncbi.nlm.nih.gov/35084966/

The spike protein of SARS-CoV-2 exhibits pathogenic characteristics and is a possible cause of post-acute sequelae,

after SARS-CoV-2 infection or COVID-19 vaccination.

COVID-19 vaccines utilise a modified, stabilised prefusion spike protein that might share similar toxic effects with its viral counterpart.

pubmed.ncbi.nlm.nih.gov/38024037/

Not the natural Uridine

Uracil is one of the four nucleobases in RNA

Adenine, cytosine, guanine

The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines

www.ncbi.nlm.nih.gov/pmc/articles/PMC8600071/

Both consisted of N1-methyl-pseudouridine-modified mRNA encoding the SARS-COVID-19 Spike protein and were delivered with a lipid nanoparticle (LNP) formulation

A possible association between COVID-19 vaccination and the incidence of POTS has been demonstrated in a cohort of 284,592 COVID-19-vaccinated individuals

Postural tachycardia syndrome (PoTS) is when your heart rate increases very quickly after getting up from sitting or lying down.

www.nhs.uk/conditions/postural-tachycardia-syndrom…

Recipients of two or more injections of the mRNA vaccines display a class switch to IgG4 antibodies.

pubmed.ncbi.nlm.nih.gov/37243095/

Abnormally high levels of IgG4

Might cause autoimmune diseases

Promote cancer growth

Autoimmune myocarditis

Other IgG 4-related diseases

There are clear implications for vaccine boosting where these and similar observations,

relating to COVID-19 vaccination and the incidence of long COVID-like symptoms are substantiated,

adding further to public health officials’ concerns.

Understanding the persistence of viral mRNA,

and viral protein and their cellular pathological effects after vaccination with and without infection is clearly required.

Because COVID-19 vaccines were approved without long-term safety data and might cause immune dysfunction,

it is perhaps premature to assume that past SARS-CoV-2 infection is the sole common factor in long COVID.

Millions worldwide experience post-acute sequelae of COVID-19 (PASC or long COVID)

Although the Australian Bureau of Statistics and other health agencies in Australia do not survey the prevalence of long COVID, it is estimated that it affects hundreds of thousands

Long COVID is a heterogeneous disease with variable cardiac, pulmonary, haematological and neurological involvement

There is no consensus on what causes lingering COVID-19 symptoms long after the acute infection has cleared.

Often unable to secure a diagnosis, patients are wont to seek multiple serial medical opinions, frequently being told their condition is due to anxiety or post-pandemic mental issues.

The median duration of long COVID symptoms is five months, but 10% of patients still experience symptoms at 12 months.

Fatigue, shortness of breath and difficulty concentrating are reported at least up to two years after SARS-CoV-2 infection.

It is still too early to say whether some individuals with long COVID might never recover.

Long COVID patients present elevated inflammatory biomarkers,

(eg interleukin-6, C-reactive protein, tumour necrosis factor-?)

Those subscribing to long COVID digital support groups report months of frustration at not being listened to, finding the health system woefully inadequate, with few primary or secondary care professionals knowing enough to offer much.

The outcome for some of those experiencing long COVID is self-prescribed medication using over-the-counter remedies and dietary changes based on potentially conflicting or misleading online information.

Some speak of a substantial proportion of their income being used in this way.

In Australia, an estimated 240,000 of those with long COVID no longer work full time.

Work absenteeism might significantly impact the nation’s economy, as in the UK.

In the US, long COVID has been declared a national emergency.

pubmed.ncbi.nlm.nih.gov/36219031/

Reduced to working part time to cope with unwellness, those with long COVID commonly report having to wait a year or more before receiving a diagnosis.

Suppressed, as usual.

T is not some ‘crank’ saying it. This video covers recent articles:

Full description, as Google loves censoring such videos.

Professor Angus Dalgleish, mRNA Vaccines Must Be Banned Once and For All

dailysceptic.org/2023/10/01/mrna-vaccines-must-be-…

www.conservativewoman.co.uk/mrna-vaccines-must-be-…

At the end of last year I reported that I was seeing melanoma patients who had been stable for years relapse after their first booster (their third injection).

The number of my patients affected has been rising ever since.

Other oncologists have contacted me from all over the world including from Australia and the U.S.

After boosters

The consensus is that it is no longer confined to melanoma but that increased incidence of:

After boosters

Lymphomas, a cancer of the lymphatic system

Leukaemias, a group of cancers that affect the blood

Kidney cancers

My colorectal cancer colleagues report an epidemic of explosive cancers (those presenting with multiple metastatic spread in the liver and elsewhere).

Those of us who knew from the beginning that the sequence of SARS-CoV-2 contained inserts which could not have possibly occurred naturally, and were similar to ones that had already been published from the Wuhan laboratory

The ‘vaccine’ did not stay at the site of injection as promised

Batch-to-batch variability

These alarming concerns seem to have been brushed off by the regulators when they should have immediately begun investigating them in depth.

Yellow Card and U.S. VAERS adverse event reports to be nothing to be worried about.

DNA contamination

So why are these cancers occurring?

T cell suppression was my first likely explanation.

However we must also now consider DNA plasmid and SV40 integration in promoting cancer development,

Reports that mRNA spike protein binds p53 and other cancer suppressor genes.

To advise booster vaccines, as is the current case, is no more and no less than medical incompetence.

No ifs or buts any longer. All mRNA vaccines must be halted and banned now.

Eurostat

Circulatory diseases, cancer: 54% of all EU deaths in 2021

ec.europa.eu/eurostat/en/web/products-eurostat-new…

In 2021 there were 5.3 million deaths in the EU

Circulatory diseases, 1.71 million (32% of all deaths).

Cancer, 1.14 million (22%).

Respiratory diseases (0.32 million; 6%)

Diseases of the digestive system (0.21 million; 4%)

Eurostat, Excess deaths 2022

ec.europa.eu/eurostat/web/products-eurostat-news/-…

April, + 12%
May, +7%
June, +7%
July, + 16%

Eurostat, 2023

ec.europa.eu/eurostat/web/products-eurostat-news/w…

Excess mortality continued

Eurostat, Jan 2024, + 3.6%

In January 2024, the highest excess mortality rates were in the Netherlands (15.3 %), Denmark (11.5 %) and Germany (9.9 %).

In January 2024, excess mortality continued to vary across the EU.

Romania, Bulgaria, Hungary, Lithuania, Croatia, Luxembourg, Slovakia, Poland, Latvia and Czechia recorded no excess deaths.

Just help them help the plants

NEVER knew this was possible, but having checked a couple of online videos I realised it is possible to heal/revive/resuscitate bees or bumblebees that get stuck inside the home, unable to fly but still alive (able to walk like an insect, however feebly).

The short story is, feed some sugar to them, possibly in a water solution (easier for them to suck in), then ‘leave them to it’. If necessary, confine them to a space where they can see the energy-boosting solution. Then, for a period of time, they become seemingly active, like pulsating or pumping their body a bit (akin to heavy breathing). Later they regain enough energy and try to fly. It’s incredible! The recovery is fast!

In my case, the hardest part was showing the bumblebee the way out (through the window).

Saving bumblebees that get stranded inside home will hopefully become more common a practice. You not only help an animal but also assist the pollination of flowers, so you help both fauna and flora.